Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Abbott Laboratories' $5.8 billion proposed purchase of Alere, a Massachusetts medical testing company, is in trouble now that multiple criminal allegations have been leveled against Alere. Abbott, apparently now reluctant, reportedly offered Alere around $50 million to release it from its agreement. Alere declined the offer, then claimed in an August 2016 suit that Abbott was dragging its feet due to a severe case of buyer's remorse.
The problems appear to stem from several legal actions now threatening Alere. The first sign of trouble came on Feb. 26, 2016, when Alere announced that it would delay the filing of its annual 10-K form with the U.S. Securities and Exchange Commission (SEC) because of concerns over its revenue recognition practices in Africa and China. The delayed form, finally filed in August 2016, contained little of major concern to the markets, but it did reveal the company's independent auditor's conclusion that Alere had not been maintaining effective internal controls over its financial reporting process. The company's August 2016 filing also showed revised financial results for fiscal years 2013, 2014 and three quarters of 2015.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
Summary Judgment Denied Defendant in Declaratory Action by Producer of To Kill a Mockingbird Broadway Play Seeking Amateur Theatrical Rights
“Baseball arbitration” refers to the process used in Major League Baseball in which if an eligible player's representative and the club ownership cannot reach a compensation agreement through negotiation, each party enters a final submission and during a formal hearing each side — player and management — presents its case and then the designated panel of arbitrators chooses one of the salary bids with no other result being allowed. This method has become increasingly popular even beyond the sport of baseball.
Executives have access to some of the company's most sensitive information, and they're increasingly being targeted by hackers looking to steal company secrets or to perpetrate cybercrimes.
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?